Aarti Drugs Limited has informed the Exchange about Copy of Newspaper Publication
AARTIDRUGS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Aarti Drugs has submitted to the stock exchanges copies of newspaper advertisements publishing its Standalone and Consolidated Financial Results for the quarter ended June 30, 2025. The results were published on July 19, 2025 in Financial Express (English) and Pratahkal (Marathi), as required under SEBI Listing Regulations. The filing was signed by Rushikesh Deole, Company Secretary and Compliance Officer. This is a routine compliance disclosure, and no specific financial numbers are mentioned in the filing itself — only the fact that the quarterly results were published in newspapers.
This is a procedural compliance filing with no direct impact on shareholders or stock price. Investors looking for the actual Q1 FY26 performance numbers should refer to the published results in Financial Express or Pratahkal, or the earlier detailed results filing submitted to the exchanges.